Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
NEB
NEB is a stimulant in the synthetic cathinone class1 that has been sold as a designer drug. It was first reported around 2011. Its effects are short-lived, and anecdotal reports suggest some similarities to those of other cathinones. It is classified as habit-forming.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Subjective Effects
Pharmacology
Pharmacodynamics
NEB has greater potency at inhibiting dopamine uptake than serotonin uptake in transfected HEK293 cells expressing human transporters.2
Pharmacokinetics
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
ModerateNEB is considered a habit-forming stimulant research chemical.
History & Culture
N-Ethylbuphedrone (NEB) was first reported around 2011 and was sold as a designer drug. It reportedly did not achieve widespread popularity.
Legality
References
Citations
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed: this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the NEB article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.